Technology Times New Jersey: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times New Jersey.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on October 16, 2025

October 16, 2025

最新消息：SINTX 加強預防感染產品組合並獲批新美國專利，可觸及 300 億美元抗病原市場

GlobeNewswire

October 16, 2025

La subsidiaria ZenaDrone de ZenaTech realizará reuniones con miembros del Congreso para destacar su innovación en drones, seguida de la presentación de sus soluciones de drones en el Foro de Defensa AUVSI

GlobeNewswire

October 16, 2025

Theriva™ Biologics anuncia una operación de incentivo de warrants por un importe bruto de 4 millones de dólares

GlobeNewswire

$Le R&D Day de Cellectis souligne le potentiel de lasmé-cel pour combler un besoin médical majeur non satisfait chez les patients atteints de LAL-B en rechute ou réfractaire$

October 16, 2025

Le R&D Day de Cellectis souligne le potentiel de lasmé-cel pour combler un besoin médical majeur non satisfait chez les patients atteints de LAL-B en rechute ou réfractaire

GlobeNewswire

October 16, 2025

Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL

GlobeNewswire

$AB Science provides intitial Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia$

October 16, 2025

AB Science provides intitial Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia

GlobeNewswire

$AB Science présente les premières données de phase 1 de la combinaison d’AB8939 et du venetoclax dans le traitement de la leucémie myéloïde aiguë réfractaire ou en rechute$

October 16, 2025

AB Science présente les premières données de phase 1 de la combinaison d’AB8939 et du venetoclax dans le traitement de la leucémie myéloïde aiguë réfractaire ou en rechute

GlobeNewswire

October 16, 2025

British Startup Tackles $300B Fake Review Crisis with Verified Restaurant Platform

GlobeNewswire

October 16, 2025

DeLeion Capital Launches as a Global Digital Asset & Financial Infrastructure Firm Bringing Institutional-Grade Solutions to Individuals, Entrepreneurs, and Enterprises

GlobeNewswire

Nicola Wealth Evolves Leadership Team for Next Phase of Growth with Key Executive Appointments

October 16, 2025

Technology Times New Jersey: Press Releases

October 2025

November 2025

December 2025

Press releases published on October 16, 2025

最新消息：SINTX 加強預防感染產品組合並獲批新美國專利，可觸及 300 億美元抗病原市場

La subsidiaria ZenaDrone de ZenaTech realizará reuniones con miembros del Congreso para destacar su innovación en drones, seguida de la presentación de sus soluciones de drones en el Foro de Defensa AUVSI

Theriva™ Biologics anuncia una operación de incentivo de warrants por un importe bruto de 4 millones de dólares

Le R&D Day de Cellectis souligne le potentiel de lasmé-cel pour combler un besoin médical majeur non satisfait chez les patients atteints de LAL-B en rechute ou réfractaire

Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL

AB Science provides intitial Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia

AB Science présente les premières données de phase 1 de la combinaison d’AB8939 et du venetoclax dans le traitement de la leucémie myéloïde aiguë réfractaire ou en rechute

British Startup Tackles $300B Fake Review Crisis with Verified Restaurant Platform

DeLeion Capital Launches as a Global Digital Asset & Financial Infrastructure Firm Bringing Institutional-Grade Solutions to Individuals, Entrepreneurs, and Enterprises

Nicola Wealth Evolves Leadership Team for Next Phase of Growth with Key Executive Appointments

Apollomics 宣布听证会取消后继续在 Nasdaq 股票市场上市

聽證會取消後，Apollomics 宣佈繼續於 The Nasdaq Stock Market 維持其上市地位

Carbon Browser and Unstoppable Domains Launch .CARBON Top-Level Domain, Defining a Privacy-First Identity Layer for Web3

New Benchmark with RETEVIS RB48 Pro, Cementing 15-Year Legacy of Industrial-Grade Innovation

Quickbase Announces New AI Tools to Empower Deskless Workforce; Customers Cut Accidents by 39% and Scale Revenue 500%

iFLYTEK AINOTE 2 Launches: A Game-Changer for Professional Productivity

Delinea Named a Leader in 2025 Gartner® Magic Quadrant™ for Privileged Access Management for Seventh Consecutive Time

DeLeion Capital launches Beginner-Friendly Asset Management Plan for Long-Term Growth

Synaptics to Report First Quarter Fiscal 2026 Results on November 6, 2025

Open-Source AI Tool by Yandex Detects Signs of Infant Cerebral Palsy With Over 90% Accuracy